An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Metformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea

A. H. Barnett; M. Dreyer; P. Lange; M. Serdarevic-Pehar;

doi:10.2337/dc05-1879

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Metformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea

Diabetes Care ◽

10.2337/dc05-1879 ◽

2006 ◽

Vol 29 (6) ◽

pp. 1282-1287 ◽

Cited By ~ 40

Author(s):

A. H. Barnett ◽

M. Dreyer ◽

P. Lange ◽

M. Serdarevic-Pehar ◽

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Safety Profile ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin

Diabetes Care ◽

10.2337/dc05-1880 ◽

2006 ◽

Vol 29 (8) ◽

pp. 1818-1825 ◽

Cited By ~ 41

Author(s):

A. H. Barnett ◽

M. Dreyer ◽

P. Lange ◽

M. Serdarevic-Pehar ◽

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Safety Profile ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Meformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea: Response to Mikhail and Cope

Diabetes Care ◽

10.2337/dc-06-1466 ◽

2006 ◽

Vol 29 (10) ◽

pp. 2333-2334 ◽

Cited By ~ 1

Author(s):

A. H. Barnett ◽

M. Dreyer ◽

P. Lange ◽

M. Serdarevic-Pehar ◽

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Safety Profile ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin: Response to Kanna and Abreu-Pacheco

Diabetes Care ◽

10.2337/dc06-2173 ◽

2007 ◽

Vol 30 (2) ◽

pp. 446-446

Author(s):

A. H. Barnett ◽

M. Dreyer ◽

P. Lange ◽

M. Serdarevic-Pehar ◽

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Safety Profile ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin: Response to Barnett et al.

Diabetes Care ◽

10.2337/dc06-2031 ◽

2007 ◽

Vol 30 (2) ◽

pp. 445-446 ◽

Cited By ~ 1

Author(s):

B. Kanna ◽

H. Abreu-Pacheco

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Safety Profile ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Meformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea: Response to Barnett et al.

Diabetes Care ◽

10.2337/dc06-1316 ◽

2006 ◽

Vol 29 (10) ◽

pp. 2332-2333

Author(s):

N. Mikhail ◽

D. Cope

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Safety Profile ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Efficacy and Safety of the Partial PPARγ Agonist Balaglitazone Compared with Pioglitazone and Placebo: A Phase III, Randomized, Parallel-Group Study in Patients with Type 2 Diabetes on Stable Insulin Therapy

10.1210/endo-meetings.2011.part4.p4.p3-467 ◽

2011 ◽

pp. P3-467-P3-467

Author(s):

Kim Henriksen ◽

Inger Byrjalsen ◽

Per Qvist ◽

Henning Beck-Nielsen ◽

Gitte Hansen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group ◽

Pparγ Agonist

Download Full-text

Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferiority Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.07.007 ◽

2012 ◽

Vol 34 (9) ◽

pp. 1892-1908.e1 ◽

Cited By ~ 53

Author(s):

Nobuya Inagaki ◽

Yoshihito Atsumi ◽

Tomonori Oura ◽

Hitoshi Saito ◽

Takeshi Imaoka

Keyword(s):

Type 2 Diabetes ◽

Safety Profile ◽

Japanese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Once Daily ◽

Parallel Group

Download Full-text

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.10.007 ◽

2006 ◽

Vol 28 (10) ◽

pp. 1556-1568 ◽

Cited By ~ 354

Author(s):

Julio Rosenstock ◽

Ronald Brazg ◽

Paula J. Andryuk ◽

Kaifeng Lu ◽

Peter Stein

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Dipeptidyl Peptidase 4 ◽

Parallel Group Study ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Parallel Group

Download Full-text

Efficacy and Safety of Empagliflozin Monotherapy for 52 Weeks in Japanese Patients with Type 2 Diabetes: A Randomized, Double-Blind, Parallel-Group Study

Advances in Therapy ◽

10.1007/s12325-015-0198-0 ◽

2015 ◽

Vol 32 (4) ◽

pp. 306-318 ◽

Cited By ~ 27

Author(s):

Takashi Kadowaki ◽

Masakazu Haneda ◽

Nobuya Inagaki ◽

Yasuo Terauchi ◽

Atsushi Taniguchi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.1187 ◽

2011 ◽

Vol 27 (4) ◽

pp. 392-401 ◽

Cited By ~ 48

Author(s):

Kim Henriksen ◽

Inger Byrjalsen ◽

Per Qvist ◽

Henning Beck-Nielsen ◽

Gitte Hansen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Partial Agonist ◽

Phase Iii ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text